乌司他丁联合奥曲肽治疗重症急性胰腺炎的临床效果.docVIP

精品论文 参考文献 乌司他丁联合奥曲肽治疗重症急性胰腺炎的临床效果 霞晓燕 石 勇 　　绵阳市人民医院 621000 　　【摘要】目的：观察分析乌司他丁联合奥曲肽治疗重症重症急性胰腺炎（AP）的临床效果。方法：选取我院2014年2月~2015年2月收治的65例重症重症急性胰腺炎患者，运用双色球随机分组法分为观察组（n=35）及对照组（n=30），对照组患者给予奥曲肽治疗，观察组患者采用乌司他丁联合奥曲肽治疗，对两组患者临床治疗效果进行比较和分析。结果：观察组患者治疗总有效率91.43%，高于对照组70.00%；观察组患者实验室指标恢复时间、住院时间较对照组更短；观察组患者并发症发生率低于对照组，差异具有统计学意义（Plt;0.05）。结论：在重症急性胰腺炎治疗过程中，乌司他丁联合奥曲肽治疗可明显缓解临床症状，提高治疗有效率，并发症少，安全可靠，值得临床推广应用。 　　【关键词】重症急性胰腺炎；乌司他丁；奥曲肽；临床效果 　　The clinical effect of ulinastatin combined with octreotide statins in the treatment of severe acute pancreatitis 　　[Abstract] Objective: To observe and analyze the ulinastatin combined with octreotide in the treatment of severe acute pancreatitis (AP) clinical effect. Methods in our hospital in 2014 February 2015 February were 65 cases of severe acute severe pancreatitis patients, uses the double chromosphere were randomly divided into observation group (n = 35) and control group (n = 30), the control group were treated with octreotide in the treatment of. In observation group were treated with ulinastatin Ding to unite the Olympic Song of peptide in the treatment, the clinical therapeutic effect of two groups of patients for comparison and analysis. Results: Observation of patients in the treatment group total effective rate was 91.43%, higher than that of the control group was 70.00%; observation group laboratory indexes in patients with recovery time, hospitalization time was shorter than that of the control; observation group patients with the complication rate was lower than the control group, the difference is statistically significant (P lt; 0.05). Conclusion: in the treatment of patients with severe acute pancreatitis (SAP) UTI Ding his combined with octreotide treatment can relieve clinical symptoms, improve the treatment efficiency, fewer complications, safe and reliable, it is worth of clinical application. 　　[Key words] severe acute pancreatitis; Ulinastatin; octreotide; clinical effect 　　重症急性胰腺炎（AP）是外科临床常见病和多发病，是多种原因使胰酶在胰腺中内激活后引起的胰腺组织消化、水肿、出